MedPath

VISIONCARE, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:2

Trial Phases

2 Phases

Early Phase 1:1
Not Applicable:10

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Not Applicable
10 (90.9%)
Early Phase 1
1 (9.1%)

International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

Not Applicable
Not yet recruiting
Conditions
Age - Related Macular Degeneration (AMD)
First Posted Date
2025-09-10
Last Posted Date
2025-09-10
Lead Sponsor
VisionCare, Inc.
Target Recruit Count
44
Registration Number
NCT07164378
Locations
🇫🇷

Centre d'Ophtalmologie Paradis-Monticelli, Marseille, France

🇫🇷

Hélios Ophtalmologie, Saint-Jean-de-Luz, France

🇫🇷

CHU de Strasbourg, Strasbourg, France

and more 8 locations

A Study of the SING IMT in an Israeli Cohort

Not Applicable
Not yet recruiting
Conditions
Age-Related Macular Degeneration
Geographic Atrophy
First Posted Date
2023-07-12
Last Posted Date
2023-07-12
Lead Sponsor
VisionCare, Inc.
Target Recruit Count
5
Registration Number
NCT05941273
Locations
🇮🇱

Wolfson Medical Center, Holon, Tel Aviv, Israel

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Not Applicable
Recruiting
Conditions
Age-Related Macular Degeneration
Geographic Atrophy
First Posted Date
2022-06-30
Last Posted Date
2024-12-03
Lead Sponsor
VisionCare, Inc.
Target Recruit Count
125
Registration Number
NCT05438732
Locations
🇺🇸

Eye Physicians of Long Beach, Long Beach, California, United States

🇺🇸

Oakland Ophthalmic Surgery, Birmingham, Michigan, United States

🇺🇸

Vance Thompson Vision, Omaha, Nebraska, United States

and more 7 locations

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

Not Applicable
Recruiting
Conditions
Age-Related Macular Degeneration
AMD
First Posted Date
2021-03-15
Last Posted Date
2023-07-28
Lead Sponsor
VisionCare, Inc.
Target Recruit Count
76
Registration Number
NCT04796545
Locations
🇩🇪

Augenklinik Städtisches Klinikum Karlsruhe, Karlsruhe, Germany

🇩🇪

Universitätsklinikum Münster Klinik für Augenheilkunde, Münster, Germany

🇮🇪

Mater Misericordiae University Hospital, Dublin, Ireland

and more 5 locations

Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

Not Applicable
Terminated
Conditions
Age Related Macular Degeneration
First Posted Date
2020-07-13
Last Posted Date
2020-07-13
Lead Sponsor
VisionCare, Inc.
Target Recruit Count
9
Registration Number
NCT04468373
Locations
🇮🇪

Mater Private Hospital, Dublin, Ireland

🇪🇸

VISSUM Ophthalmological Corporation, Alicante, Spain

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.